Could Red-Light Therapy Change Myopia Care?  - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Could Red-Light Therapy Change Myopia Care? 

Across 28 trials, pediatric patients receiving therapy had less myopia progression over 12 months, though long-term risks remain under study.

  • By

  • Kerri Miller

  • April 8, 2026

  • 4 min

Share

  • 1

    Repeated low-level red-light therapy may reduce myopia progression in pediatric patients over 12 months.

  • 2

    At 12 months, treatment showed a 0.68 diopter improvement in spherical equivalent refraction compared to controls.

  • 3

    Patients with higher baseline myopia experienced greater benefits from red-light therapy.

  • 4

    Short-term structural parameters remained stable, with no severe treatment-related adverse events reported.

  • 5

    Further long-term trials are needed to assess retinal safety and cumulative effects of red-light therapy.

Original Source(s)

Could Red-Light Therapy Change Myopia Care? 

  • by Kerri Miller

  • April 8, 2026

Related Content

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.

Glycemic variability may signal retinal changes

Greater glucose fluctuations but not HbA1c were associated with neuroretinal alterations over 3 years in pediatric patients with type 1 diabetes.

A Strategic Shift in Vision Healthcare

The clinical and financial imperative for surgical vision correction over conventional optical aids